These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 23689820

  • 1. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, Stukel TA.
    JAMA Intern Med; 2013 Jul 08; 173(13):1175-85. PubMed ID: 23689820
    [Abstract] [Full Text] [Related]

  • 2. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A, Croxford R, To T, Stanbrook MB, Upshur R, Sanchez-Romeu P, Stukel T.
    Ann Intern Med; 2011 May 03; 154(9):583-92. PubMed ID: 21536937
    [Abstract] [Full Text] [Related]

  • 3. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study.
    Stephenson A, Seitz D, Bell CM, Gruneir A, Gershon AS, Austin PC, Fu L, Anderson GM, Rochon PA, Gill SS.
    Arch Intern Med; 2011 May 23; 171(10):914-20. PubMed ID: 21606096
    [Abstract] [Full Text] [Related]

  • 4. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA.
    JAMA; 2014 Sep 17; 312(11):1114-21. PubMed ID: 25226477
    [Abstract] [Full Text] [Related]

  • 5. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug 17; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 6. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L, Forget A, Ramachandran S.
    Clin Ther; 2010 Jul 17; 32(7):1320-8. PubMed ID: 20678680
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 17; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 8. Inhaled anticholinergic drugs and risk of acute urinary retention.
    Afonso AS, Verhamme KM, Stricker BH, Sturkenboom MC, Brusselle GG.
    BJU Int; 2011 Apr 17; 107(8):1265-72. PubMed ID: 20880196
    [Abstract] [Full Text] [Related]

  • 9. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
    Dong YH, Chang CH, Gagne JJ, Hsu CL, Lai MS.
    Pharmacotherapy; 2016 Jan 17; 36(1):26-37. PubMed ID: 26799347
    [Abstract] [Full Text] [Related]

  • 10. The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients.
    Kim J, Kim K, Kim Y, Yoo KH, Lee CK, Yoon HK, Kim YS, Park YB, Lee JH, Oh YM, Lee SD, Lee SW.
    Respir Med; 2014 Jan 17; 108(1):153-61. PubMed ID: 23993445
    [Abstract] [Full Text] [Related]

  • 11. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".
    Singh S, Furberg CD.
    Arch Intern Med; 2011 May 23; 171(10):920-2. PubMed ID: 21606097
    [No Abstract] [Full Text] [Related]

  • 12. [Are there cardiovascular adverse effects of inhaled anticholinergics?].
    Nagy LB.
    Orv Hetil; 2015 Aug 02; 156(31):1246-52. PubMed ID: 26211748
    [Abstract] [Full Text] [Related]

  • 13. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM, Bollmeier SG, Finnegan PM.
    Ann Pharmacother; 2008 Dec 02; 42(12):1832-42. PubMed ID: 18957624
    [Abstract] [Full Text] [Related]

  • 14. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF.
    Expert Opin Investig Drugs; 2010 Feb 02; 19(2):257-64. PubMed ID: 20047505
    [Abstract] [Full Text] [Related]

  • 15. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.
    Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA, Korducki L, Cassino C, Kesten S.
    Ann Intern Med; 2005 Sep 06; 143(5):317-26. PubMed ID: 16144890
    [Abstract] [Full Text] [Related]

  • 16. Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study.
    Wang MT, Liou JT, Lin CW, Tsai CL, Wang YH, Hsu YJ, Lai JH.
    JAMA Intern Med; 2018 Feb 01; 178(2):229-238. PubMed ID: 29297057
    [Abstract] [Full Text] [Related]

  • 17. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 18. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S, Loke YK, Enright P, Furberg CD.
    Postgrad Med J; 2014 Apr 10; 90(1062):205-7. PubMed ID: 24643260
    [Abstract] [Full Text] [Related]

  • 19. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM, POET-COPD Investigators.
    N Engl J Med; 2011 Mar 24; 364(12):1093-1103. PubMed ID: 21428765
    [Abstract] [Full Text] [Related]

  • 20. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD.
    Verhamme KM, Afonso AS, van Noord C, Haag MD, Koudstaal PJ, Brusselle GG, Sturkenboom MC.
    Pulm Pharmacol Ther; 2012 Feb 24; 25(1):19-26. PubMed ID: 22051450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.